UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

Nanobodies that Neutralize HIV

Vaccines (Basel), 2019-07, Vol.7 (3), p.77

2019

Volltextzugriff (PDF)

Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum

Proteomics (Weinheim), 2007-11, Vol.7 (22), p.4070-4081

2007

Volltextzugriff (PDF)

Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules

PloS one, 2011-04, Vol.6 (4), p.e17665-e17665

2011

Volltextzugriff (PDF)

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (47), p.20565-20570

2010

Volltextzugriff (PDF)

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells

Antibodies (Basel), 2019-06, Vol.8 (2), p.26

2019

Volltextzugriff (PDF)

Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies

Scientific reports, 2022-08, Vol.12 (1), p.13413-13413, Article 13413

2022

Volltextzugriff (PDF)

Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies

Molecular cancer therapeutics, 2015-11, Vol.14 (11), p.2527-2540

2015

Volltextzugriff (PDF)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions

Frontiers in immunology, 2022-05, Vol.13, p.893648-893648

2022

Volltextzugriff (PDF)

Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C

PloS one, 2012-03, Vol.7 (3), p.e33298

2012

Volltextzugriff (PDF)

Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo

Human molecular genetics, 2009-05, Vol.18 (10), p.1849-1859

2009

Volltextzugriff (PDF)

Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH

PloS one, 2011-10, Vol.6 (10), p.e26299-e26299

2011

Volltextzugriff (PDF)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions

Frontiers in immunology, 2022-11, Vol.13, p.1091668-1091668

2022

Volltextzugriff (PDF)

Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (2), p.513-518

2013

Volltextzugriff (PDF)

Nanobodies®Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion

The Journal of infectious diseases, 2011-12, Vol.204 (11), p.1692-1701

2011

Volltextzugriff (PDF)

Differential recognition of vascular and parenchymal beta amyloid deposition

Neurobiology of aging, 2011-10, Vol.32 (10), p.1774-1783

2011

Volltextzugriff (PDF)

Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120

Journal of Virology, 2008-12, Vol.82 (24), p.12069-12081

2008

Volltextzugriff (PDF)

Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1

PLoS pathogens, 2014-12, Vol.10 (12), p.e1004552-e1004552

2014

Volltextzugriff (PDF)

Novel Contrasting and Labeling Procedures for Correlative Microscopy of Thawed Cryosections

The journal of histochemistry and cytochemistry, 2013-03, Vol.61 (3), p.236-247

2013

Volltextzugriff (PDF)

Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells

PloS one, 2012-04, Vol.7 (4), p.e35630

2012

Volltextzugriff (PDF)

Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology

Journal of immunological methods, 2007-07, Vol.324 (1), p.1-12

2007

Volltextzugriff (PDF)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes

Antibodies (Basel), 2019-06, Vol.8 (2), p.38

2019

Volltextzugriff (PDF)

Isolation of Llama Antibody Fragments for Prevention of Dandruff by Phage Display in Shampoo

Applied and Environmental Microbiology, 2005, Vol.71 (1), p.442-450

2005

Volltextzugriff (PDF)

Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody

Human molecular genetics, 2006-01, Vol.15 (1), p.105-111

2006

Volltextzugriff (PDF)

VIS2FIX: A High‐Speed Fixation Method for Immuno‐Electron Microscopy

Traffic (Copenhagen, Denmark), 2011-07, Vol.12 (7), p.806-814

2011

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(150)
Buchkapitel
(4)

Sprache

Englisch
(154)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(111)
Life Sciences & Biomedicine
(102)
Animals
(53)
Biological And Medical Sciences
(49)
Fundamental And Applied Biological Sciences. Psychology
(46)
Humans
(43)
Saccharomyces Cerevisiae
(41)
Biochemistry & Molecular Biology
(37)
Microbiology
(36)
Biotechnology & Applied Microbiology
(30)
Molecular Sequence Data
(30)
Biotechnology
(28)
Saccharomyces Cerevisiae - Genetics
(26)
Amino Acid Sequence
(25)
Antibodies
(24)
Saccharomyces Cerevisiae - Metabolism
(21)
Camelids, New World - Immunology
(20)
Base Sequence
(19)
Immunology
(18)
Proteins
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nanobodies that Neutralize HIV

Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum

Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells

Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies

Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions

Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C

Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo

Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions

Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives

Nanobodies®Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion

Differential recognition of vascular and parenchymal beta amyloid deposition

Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120

Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1

Novel Contrasting and Labeling Procedures for Correlative Microscopy of Thawed Cryosections

Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells

Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes

Isolation of Llama Antibody Fragments for Prevention of Dandruff by Phage Display in Shampoo

Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition

VIS2FIX: A High‐Speed Fixation Method for Immuno‐Electron Microscopy

Suchergebnisse filtern